Tax Management India. Com
Law and Practice  :  Digital eBook
Research is most exciting & rewarding
  TMI - Tax Management India. Com
Follow us:
  Facebook   Twitter   Linkedin   Telegram

Home Case Index All Cases Income Tax Income Tax + AT Income Tax - 2017 (1) TMI AT This

  • Login
  • Cases Cited
  • Referred In
  • Summary

Forgot password       New User/ Regiser

⇒ Register to get Live Demo



 

2017 (1) TMI 1109 - AT - Income Tax


Issues Involved:
1. Disallowance of overriding commission paid to Associated Enterprise.
2. Disallowance of deduction u/s. 10B of the Act in respect of Ahmednagar Unit.
3. Disallowance of trade mark registration and overseas product registration charges u/s. 35(2AB).
4. Exclusion of interest on loans to employees for deduction u/s. 80IB.
5. Reallocation of R & D expenses @ 12.5% for computing deduction u/s. 80IB.
6. Treatment of foreign exchange fluctuation gain.
7. Disallowance of deduction u/s. 10B of Ahmednagar Unit for computing book profit.
8. Addition of sales made to Sun Pharmaceuticals Industries.
9. Disallowance of expenses incurred on behalf of Sun Pharmaceutical Industries.
10. Rework of Arm’s Length Price with regard to commission paid to AE.
11. Grant of exemption u/s. 10B in respect of Panoli Unit.
12. Inclusion of interest on overdue bills in gross sales while computing deduction u/s. 80IB.
13. Reallocation of R & D expenses.
14. Exclusion of income of Panoli Unit for calculation of Book Profit.
15. Recalculation of disallowance of expenses incurred on behalf of Sun Pharmaceutical Industries.

Detailed Analysis:

1. Disallowance of overriding commission paid to Associated Enterprise:
The Tribunal decided in favor of the assessee, directing the A.O to delete the entire transfer pricing adjustment. The Tribunal found that the payment of 3% + 1% overriding commission was at arm's length and there were no comparable cases brought by the revenue to prove otherwise.

2. Disallowance of deduction u/s. 10B of the Act in respect of Ahmednagar Unit:
The Tribunal directed the A.O to allow the claim of deduction u/s. 10B for the Ahmednagar Unit, noting that the LOP cancellation pertained to a later financial year and should not affect the current assessment year.

3. Disallowance of trade mark registration and overseas product registration charges u/s. 35(2AB):
The Tribunal followed its earlier decision favoring the assessee, directing the A.O to delete the disallowance. It was concluded that the expenses incurred were for validation and confirmation of research carried out, not merely for registration.

4. Exclusion of interest on loans to employees for deduction u/s. 80IB:
The Tribunal directed the A.O to decide the issue afresh in light of the Supreme Court's decision in Liberty India, considering the inclusion of income from scrap sale and miscellaneous income.

5. Reallocation of R & D expenses @ 12.5% for computing deduction u/s. 80IB:
The Tribunal upheld the reallocation of R & D expenses only to raw materials, as the revenue authorities had generalized the statement of the Senior Vice President. The A.O was directed to restrict the reallocation accordingly.

6. Treatment of foreign exchange fluctuation gain:
The Tribunal restored the issue to the A.O for fresh adjudication, emphasizing that legal issues can be raised at any stage, and the A.O should decide these issues after considering earlier assessment years.

7. Disallowance of deduction u/s. 10B of Ahmednagar Unit for computing book profit:
As the Tribunal directed the A.O to allow the deduction u/s. 10B for the Ahmednagar Unit, it also directed the A.O to allow the deduction for computing book profit.

8. Addition of sales made to Sun Pharmaceuticals Industries:
The Tribunal directed the A.O to delete the addition, noting that provisions of section 40A(2) were not applicable to the transaction of credit in nature and no specific section was mentioned for the addition.

9. Disallowance of expenses incurred on behalf of Sun Pharmaceutical Industries:
The Tribunal directed the A.O to delete the addition, stating that the expenses were incurred for the purposes of the business and the revenue authorities did not prove otherwise.

10. Rework of Arm’s Length Price with regard to commission paid to AE:
The Tribunal dismissed the revenue's ground, aligning with its decision in favor of the assessee on the same issue in the assessee’s appeal.

11. Grant of exemption u/s. 10B in respect of Panoli Unit:
The Tribunal dismissed the revenue's ground, following its earlier decision confirming the exemption u/s. 10B for the Panoli Unit.

12. Inclusion of interest on overdue bills in gross sales while computing deduction u/s. 80IB:
The Tribunal upheld the First Appellate Authority's decision, which followed the Jurisdictional High Court's ruling in Nirma Industries Ltd., including the interest on overdue bills in the computation.

13. Reallocation of R & D expenses:
The Tribunal confirmed the findings of the First Appellate Authority, dismissing the revenue's ground for reallocation of R & D expenses.

14. Exclusion of income of Panoli Unit for calculation of Book Profit:
The Tribunal upheld the First Appellate Authority's decision to exclude the income of the Panoli Unit for calculating book profit u/s. 115JB, following earlier Tribunal decisions.

15. Recalculation of disallowance of expenses incurred on behalf of Sun Pharmaceutical Industries:
The Tribunal dismissed the revenue's ground, following its earlier decision favoring the assessee on the same issue in the assessee’s appeal.

Conclusion:
The Tribunal's judgment largely favored the assessee, directing the A.O to delete various disallowances and adjustments, and to re-examine certain issues in light of earlier decisions and legal precedents. The revenue's appeal was dismissed on several grounds, affirming the assessee's claims and deductions.

 

 

 

 

Quick Updates:Latest Updates